Macquarie Group’s Voyager Therapeutics VYGR Stock Holding History

Macquarie Group’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,700	Closed	-$27K	–	1496
2025 Q3	$27K	Hold	5,700	–	–	﹤0.01%	1544
2025 Q2	$18K	Hold	5,700	–	–	﹤0.01%	1618
2025 Q1	$19K	Hold	5,700	–	–	﹤0.01%	1592
2024 Q4	$32K	Hold	5,700	–	–	﹤0.01%	1568
2024 Q3	$33K	Hold	5,700	–	–	﹤0.01%	1604
2024 Q2	$45K	Hold	5,700	–	–	﹤0.01%	1614
2024 Q1	$53K	Hold	5,700	–	–	﹤0.01%	1560
2023 Q4	$48K	Hold	5,700	–	–	﹤0.01%	1595
2023 Q3	$44K	Hold	5,700	–	–	﹤0.01%	1587
2023 Q2	$65K	Hold	5,700	–	–	﹤0.01%	1607
2023 Q1	$44K	Hold	5,700	–	–	﹤0.01%	1643
2022 Q4	$35K	Hold	5,700	–	–	﹤0.01%	1678
2022 Q3	$34K	Hold	5,700	–	–	﹤0.01%	2055
2022 Q2	$34K	Hold	5,700	–	–	﹤0.01%	2153
2022 Q1	$43	Sell	5,700 -465	-8%	-$2.07K	﹤0.01%	2192
2021 Q4	$16K	Hold	6,165	–	–	﹤0.01%	2454
2021 Q3	$16K	Hold	6,165	–	–	﹤0.01%	2492
2021 Q2	$26K	Hold	6,165	–	–	﹤0.01%	2312
2021 Q1	$29K	Sell	6,165 -220	-3%	-$1.5K	﹤0.01%	2198
2020 Q4	$46K	Hold	6,385	–	–	﹤0.01%	2057
2020 Q3	$68K	Hold	6,385	–	–	﹤0.01%	1880
2020 Q2	$81K	Buy	6,385 +685	+12%	+$7.97K	﹤0.01%	1815
2020 Q1	$52K	Hold	5,700	–	–	﹤0.01%	1803
2019 Q4	$80K	Hold	5,700	–	–	﹤0.01%	1810
2019 Q3	$98K	Hold	5,700	–	–	﹤0.01%	1744
2019 Q2	$155K	Hold	5,700	–	–	﹤0.01%	1631
2019 Q1	$109K	Buy	5,700 +5,400	+1,800%	+$70.3K	﹤0.01%	1522
2018 Q4	$3K	Hold	300	–	–	﹤0.01%	2164
2018 Q3	$6K	Sell	300 -1,700	-85%	-$32.6K	﹤0.01%	2054
2018 Q2	$39K	Buy	+2,000	New	+$39.5K	﹤0.01%	1980

Other funds holding VYGR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Macquarie Group's VYGR Position: Q4 2025 in Review

Macquarie Group sold out of Voyager Therapeutics (VYGR) in Q4 2025, closing a stake of 5,700 shares — an estimated $27K sold.

Macquarie Group first reported a position in VYGR in Q2 2018 and held it in 30 quarters. The position peaked at $155K in Q2 2019. 125 funds tracked by Wall St. Rank hold VYGR as of Q4 2025.

Macquarie Group reported no remaining Voyager Therapeutics position as of Q4 2025 after selling out during the quarter.
Macquarie Group sold 5,700 Voyager Therapeutics shares in Q4 2025, an estimated $27K.
Macquarie Group first reported a position in Voyager Therapeutics in Q2 2018 and held it in 30 quarters.
Macquarie Group's Voyager Therapeutics position peaked at $155K in Q2 2019.
125 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.